pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
996
stories
Oct 1, 26
Sanofi, Regeneron broaden alliance to find their next Dupixent
biopharma dive
Oct 1, 26
Merck’s antibody impresses with ‘highly competitive’ data in chronic skin disease
biospace
Oct 1, 26
Pfizer’s eczema drug clears skin in mid-stage trial
biopharma dive
Oct 1, 26
Foghorn lays off 40% of staff after Lilly collaboration ends
biospace
Oct 1, 26
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events
biospace
Oct 1, 26
Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor
biospace
Oct 1, 26
STAT+: Why a Huntington’s patient isn’t fazed by the waning effect of UniQure’s gene therapy
stat
Oct 1, 26
STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await
stat
Oct 1, 26
Sanofi builds on immunology alliance with Regeneron for $1B upfront
endpoints
Oct 1, 26
Foghorn lays off 40% of employees as Lilly cancer collab collapses over poor data
fiercebiotech
Oct 1, 26
STAT+: Sanofi, Regeneron expand partnership after Dupixent success
stat
Oct 1, 26
Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D
fiercebiotech
Oct 1, 26
Gias Foods, Inc. Recalls Bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Risk
fda recalls
Sep 30, 26
Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
biopharma dive
Sep 30, 26
FDA starts review of Roche’s multiple sclerosis pill
biopharma dive
Sep 30, 26
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
biospace
Sep 30, 26
Amgen reveals 6-point drop in lupus severity behind phase 2 win for Horizon antibody
fiercebiotech
Sep 30, 26
Biopharma needs to reward scientists' judgment
biospace
Sep 30, 26
Biopharma needs to reward scientists' judgment
biospace
Sep 29, 26
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
stat
Sep 29, 26
Enanta sheds staffers as key antiviral, immunology readouts loom
fiercebiotech
Sep 29, 26
Spark co-founder Steven Altschuler is back with an immune-resetting biotech
endpoints
Sep 29, 26
ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’
biopharma dive
Sep 29, 26
Highlight Therapeutics illuminates positive ph. 2 topline data in high-risk skin cancer
fiercebiotech
Sep 29, 26
Researchers slow neurodegeneration in mice by barring T cells from the brain
stat
Sep 29, 26
Biopharma recruiters see ‘signs of recovery’ as layoffs remain cool in Q3’26
fiercebiotech
Sep 29, 26
Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui
fiercebiotech
Sep 28, 26
‘We’re so close to the tech companies’: Genentech CEO talks Fierce through vision for the future
fiercebiotech
Sep 28, 26
ai3Bio emerging from stealth to ‘take the gun out of the hands of the immune system’
fiercebiotech
Sep 28, 26
An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus
biopharma dive
← prev
page 12 of 34
next →